1. Home
  2. ASBPW vs OPCH Comparison

ASBPW vs OPCH Comparison

Compare ASBPW & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASBPW
  • OPCH
  • Stock Information
  • Founded
  • ASBPW N/A
  • OPCH N/A
  • Country
  • ASBPW United States
  • OPCH United States
  • Employees
  • ASBPW N/A
  • OPCH N/A
  • Industry
  • ASBPW Biotechnology: Pharmaceutical Preparations
  • OPCH Medical/Nursing Services
  • Sector
  • ASBPW Health Care
  • OPCH Health Care
  • Exchange
  • ASBPW Nasdaq
  • OPCH Nasdaq
  • Market Cap
  • ASBPW N/A
  • OPCH N/A
  • IPO Year
  • ASBPW 2022
  • OPCH N/A
  • Fundamental
  • Price
  • ASBPW N/A
  • OPCH $32.02
  • Analyst Decision
  • ASBPW
  • OPCH Buy
  • Analyst Count
  • ASBPW 0
  • OPCH 7
  • Target Price
  • ASBPW N/A
  • OPCH $33.00
  • AVG Volume (30 Days)
  • ASBPW N/A
  • OPCH 2.2M
  • Earning Date
  • ASBPW N/A
  • OPCH 04-29-2025
  • Dividend Yield
  • ASBPW N/A
  • OPCH N/A
  • EPS Growth
  • ASBPW N/A
  • OPCH N/A
  • EPS
  • ASBPW N/A
  • OPCH 1.23
  • Revenue
  • ASBPW N/A
  • OPCH $4,998,202,000.00
  • Revenue This Year
  • ASBPW N/A
  • OPCH $10.80
  • Revenue Next Year
  • ASBPW N/A
  • OPCH $8.63
  • P/E Ratio
  • ASBPW N/A
  • OPCH $26.03
  • Revenue Growth
  • ASBPW N/A
  • OPCH 16.17
  • 52 Week Low
  • ASBPW N/A
  • OPCH $21.39
  • 52 Week High
  • ASBPW N/A
  • OPCH $35.53
  • Technical
  • Relative Strength Index (RSI)
  • ASBPW N/A
  • OPCH 39.77
  • Support Level
  • ASBPW N/A
  • OPCH $30.85
  • Resistance Level
  • ASBPW N/A
  • OPCH $32.68
  • Average True Range (ATR)
  • ASBPW 0.00
  • OPCH 1.34
  • MACD
  • ASBPW 0.00
  • OPCH -0.32
  • Stochastic Oscillator
  • ASBPW 0.00
  • OPCH 25.38

About ASBPW Aspire Biopharma Holdings Inc. Warrant

Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.

Share on Social Networks: